Currently, there are 436.18M common shares owned by the public and among those 318.80M shares have been available to trade.
The company’s stock has a 5-day price change of 8.67% and -9.20% over the past three months. PSEC shares are trading -22.54% year to date (YTD), with the 12-month market performance down to -19.02% lower. It has a 12-month low price of $4.15 and touched a high of $6.30 over the same period. PSEC has an average intraday trading volume of 3.09 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -5.27%, -9.84%, and -13.49% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Prospect Capital Corp (NASDAQ: PSEC) shares accounts for 9.49% of the company’s 436.18M shares outstanding.
It has a market capitalization of $2.02B and a beta (3y monthly) value of 0.98. The stock’s trailing 12-month PE ratio is 13.65, while the earnings-per-share (ttm) stands at $0.34. The company has a PEG of 2.73. Price movements for the stock have been influenced by the stock’s volatility, which stands at 2.70% over the week and 2.63% over the month.
Earnings per share for the fiscal year are expected to decrease by -40.20%, and -18.00% over the next financial year. EPS should shrink at an annualized rate of 5.00% over the next five years, compared to 8.90% over the past 5-year period.
Wells Fargo coverage for the Prospect Capital Corp (PSEC) stock in a research note released on June 25, 2020 offered a Underweight rating with a price target of $4.50. Raymond James was of a view on April 20, 2020 that the stock is Underperform, while Barclays gave the stock Underweight rating on January 22, 2019, issuing a price target of $7- $6. Raymond James on their part issued Mkt Perform rating on August 30, 2017.
